EU

enCore is not yet a real business by its own admission: the 10-K states it remains an "Exploration Stage Issuer" with no proven or probable reserves under S-K 1300, even though it has begun extraction at Rosita and Alta Mesa. That single disclosure reframes everything — you are buying a pre-reserve commodity venture, not a producer with defined economics. The numbers confirm the fragility: FY2025 revenue FELL 26% to $43.2M (from $58.3M), the wrong direction for a company that needs to be scaling, while the net loss stayed deep at -$56.9M and the operating margin was -152%. Gross profit of $9.7M is dwarfed by the cost structure, so profitability is nowhere in sight.

The balance sheet is where the risk concentrates. Total liabilities jumped 132% to $172M (including $110M of long-term debt) while equity shrank 20% to $229M and the accumulated deficit widened to -$208M. Against that, operating cash flow was -$25.0M and capex was $20.0M — roughly $45M of annual cash outflow against just $52.4M of cash on hand. That implies little more than a year of self-funded runway, so further dilution (shares already +4.3% YoY) or additional debt is close to inevitable. A shrinking top line, negative returns on capital (ROE -24.8%), and a rising debt load is a poor combination to underwrite.